Diabetes Metab Syndr 14(4):289292 Brierley DI et al (2021) Central and peripheral GLP-1 systems independently suppress eating
However, Retatrutide remains investigational, and the safety profile is still developing
Appetite Regulation: Beyond its direct metabolic effects, semaglutide also influences centers in the brain that control appetite and cravings, leading to a reduction in hunger and an improved ability to manage portion sizes
ALCAR and KET increased rCMRglc at similar degrees in prefrontal, somatosensory, and cingulate cortices, and KET increased rCMRglc at a different, much larger, degree in limbic and dopaminergic areas
A phase 2 trial assessing mazdutide 3, 4.5 and 6 mg in a Chinese population with overweight/obesity demonstrates up to 11.3% WL after 24 weeks of treatment compared to 1% weight gain with placebo [70]